Strategies for targeting T-cells in allergic diseases and asthma
- 11 July 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 112 (2) , 489-500
- https://doi.org/10.1016/j.pharmthera.2006.05.005
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cellsEuropean Journal of Immunology, 2005
- The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 2005
- Repression of Interleukin-5 Transcription by the Glucocorticoid Receptor Targets GATA3 Signaling and Involves Histone Deacetylase RecruitmentJournal of Biological Chemistry, 2005
- Trichostatin A attenuates airway inflammation in mouse asthma modelClinical and Experimental Allergy, 2004
- New asthma drugs acting on gene expressionJournal of Cellular and Molecular Medicine, 2003
- The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in RodentsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil ActivationThe Journal of Experimental Medicine, 2003
- Sensitivity of IL‐5 production to the cAMP‐dependent pathway in human T cells is reduced by exogenous IL‐2 in a phosphoinositide 3‐kinase‐dependent wayEuropean Journal of Immunology, 2003
- Role of type 1 and type 2 T helper cells in allergic diseasesCurrent Opinion in Immunology, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992